Genomics and Prognosis in GI Cancers
- Conditions
- GI CancerLiver Cancer
- Registration Number
- NCT05767697
- Lead Sponsor
- National Health Research Institutes, Taiwan
- Brief Summary
This study aims to collect biospecimens and explore the correlation of genomics and prognosis in alimentary tract cancers.
- Detailed Description
In this study, the investigators will collect clinical specimens of alimentary tract cancers and perform DNA and RNA analysis to identify genetic alterations for the development of a comprehensive somatic mutation databases and investigate their potential correlation with clinical, radiological and pathological variables. The genomics study included but not limited to target gene panel sequencing, whole exome sequencing, whole genome sequencing, bulk RNA sequencing, single cell RNA sequencing and metagenomics.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1000
- Able to sign the informed consent
- Age >= 20
- Histology proved pancreatic cancer, esophageal cancer, gastric cancer, hepatocellular carcinoma, cholangiocarcinoma, colorectal cancer
- Agree to provide tumor/normal tissue including but not limited to surgical specimen, biopsy, cytology specimen, bile, urine or stool
- Agree to receive blood sampling 20ml at first time and 10ml during each follow-up (total sampling amount no more than 30ml per month)
- Cannot cooperate with blood sampling
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of subjects who still survive at 1 year 1 year 1 year overall survival rate
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
National Institute of Cancer Research
🇨🇳Tainan, Taiwan
National Cheng-Kung University Hospital
🇨🇳Tainan, Taiwan